Important molecular genetic markers of colorectal cancer

被引:86
作者
Kudryavtseva, Anna V. [1 ,2 ]
Lipatova, Anastasia V. [1 ]
Zaretsky, Andrew R. [3 ]
Moskalev, Alexey A. [1 ]
Fedorova, Maria S. [1 ,2 ]
Rasskazova, Anastasiya S. [1 ]
Shibukhova, Galina A. [2 ]
Snezhkina, Anastasiya V. [1 ]
Kaprin, Andrey D. [2 ]
Alekseev, Boris Y. [2 ]
Dmitriev, Alexey A. [1 ]
Krasnov, George S. [1 ,4 ]
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia
[2] Minist Healthcare Russian Federat, Natl Med Res Radiol Ctr, Moscow, Russia
[3] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
[4] Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
colorectal cancer; molecular markers; chromosomal instability; microsatellite instability; CpG island methylator phenotype; ISLAND METHYLATOR PHENOTYPE; OXALIPLATIN-BASED CHEMOTHERAPY; MESSENGER-RNA EXPRESSION; POPULATION-BASED SERIES; APC TUMOR-SUPPRESSOR; AURORA-A EXPRESSION; NF-KAPPA-B; MICROSATELLITE-INSTABILITY; COLON-CANCER; CHROMOSOMAL INSTABILITY;
D O I
10.18632/oncotarget.9796
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) ranks third in the incidences of cancer morbidity and mortality worldwide. CRC is rather heterogeneous with regard to molecular genetic characteristics and pathogenic pathways. A wide spectrum of biomarkers is used for molecular subtype determination, prognosis, and estimation of sensitivity to different drugs in practice. These biomarkers can include germline and somatic mutations, chromosomal aberrations, genomic abnormalities, gene expression alterations at mRNA or protein level and changes in DNA methylation status. In the present review we discuss the most important and well-studied CRC biomarkers, and their potential clinical significance and current approaches to molecular classification of colorectal tumors.
引用
收藏
页码:53959 / 53983
页数:25
相关论文
共 50 条
  • [41] Advances in prognostic markers for colorectal cancer
    Duan, Lili
    Yang, Wanli
    Wang, Xiaoqian
    Zhou, Wei
    Zhang, Yujie
    Liu, Jinqiang
    Zhang, Hongwei
    Zhao, Qingchuan
    Hong, Liu
    Fan, Daiming
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (04) : 313 - 324
  • [42] Molecular biology of colorectal cancer in clinical practice
    Kit, O. I.
    Vodolazhsky, D. I.
    MOLECULAR BIOLOGY, 2015, 49 (04) : 471 - 479
  • [43] The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
    De Palma, Fatima Domenica Elisa
    D'Argenio, Valeria
    Pol, Jonathan
    Kroemer, Guido
    Maiuri, Maria Chiara
    Salvatore, Francesco
    CANCERS, 2019, 11 (07)
  • [44] The state of contemporary molecular diagnostics of colorectal cancer
    Zelazowski, Maciej J.
    Bednarek, Andrzej K.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2011, 15 (04): : 229 - 233
  • [45] Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-Onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer
    Alvaro, Edurne
    Cano, Juana M.
    Garcia, Juan L.
    Brandariz, Lorena
    Olmedillas-Lopez, Susana
    Arriba, Maria
    Rueda, Daniel
    Rodriguez, Yolanda
    Canete, Angel
    Arribas, Julia
    Inglada-Perez, Lucia
    Perez, Jessica
    Gomez, Carlos
    Garcia-Arranz, Mariano
    Garcia-Olmo, Damian
    Goel, Ajay
    Urioste, Miguel
    Gonzalez-Sarmiento, Rogelio
    Perea, Jose
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04):
  • [46] Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer
    Poole, Elizabeth M.
    Curtin, Karen
    Hsu, Li
    Duggan, David J.
    Makar, Karen W.
    Xiao, Liren
    Carlson, Christopher S.
    Caan, Bette J.
    Potter, John D.
    Slattery, Martha L.
    Ulrich, Cornelia M.
    CANCER EPIDEMIOLOGY, 2012, 36 (02) : E104 - E110
  • [47] Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach
    LeGolvan, Mark P.
    Taliano, Ross J.
    Resnick, Murray B.
    HUMAN PATHOLOGY, 2012, 43 (08) : 1157 - 1168
  • [48] Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)
    Maria Wielandt, Ana
    Villarroel, Cynthia
    Hurtado, Claudia
    Simian, Daniela
    Zamorano, Diego
    Martinez, Maripaz
    Castro, Magdalena
    Teresa Vial, Maria
    Kronberg, Udo
    Lopez-Kostner, Francisco
    REVISTA MEDICA DE CHILE, 2017, 145 (04) : 419 - 430
  • [49] Molecular phenotypes of colorectal cancer and potential clinical applications
    Kocarnik, Jonathan M.
    Shiovitz, Stacey
    Phipps, Amanda I.
    GASTROENTEROLOGY REPORT, 2015, 3 (04): : 269 - 276
  • [50] Elucidating the molecular aspects of colorectal cancer and their clinical importance
    Sanz-Garcia, Enrique
    Marino, Donatella
    Elez, Elena
    Macarulla, Teresa
    Capdevila, Jaume
    Alsina, Maria
    Argiles, Guillem
    Sauri, Tamara
    Tabernero, Josep
    COLORECTAL CANCER, 2015, 4 (04) : 175 - 183